263 related articles for article (PubMed ID: 32484800)
1. Posttranslational modifications define course of prion strain adaptation and disease phenotype.
Makarava N; Chang JC; Molesworth K; Baskakov IV
J Clin Invest; 2020 Aug; 130(8):4382-4395. PubMed ID: 32484800
[TBL] [Abstract][Full Text] [Related]
2. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
3. From Posttranslational Modifications to Disease Phenotype: A Substrate Selection Hypothesis in Neurodegenerative Diseases.
Baskakov IV
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477465
[TBL] [Abstract][Full Text] [Related]
4. Role of sialylation of N-linked glycans in prion pathogenesis.
Makarava N; Baskakov IV
Cell Tissue Res; 2023 Apr; 392(1):201-214. PubMed ID: 35088180
[TBL] [Abstract][Full Text] [Related]
5. Region-Specific Sialylation Pattern of Prion Strains Provides Novel Insight into Prion Neurotropism.
Makarava N; Chang JC; Baskakov IV
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012886
[TBL] [Abstract][Full Text] [Related]
6. Prion replication environment defines the fate of prion strain adaptation.
Katorcha E; Gonzalez-Montalban N; Makarava N; Kovacs GG; Baskakov IV
PLoS Pathog; 2018 Jun; 14(6):e1007093. PubMed ID: 29928047
[TBL] [Abstract][Full Text] [Related]
7. Non-genetic propagation of strain-specific properties of scrapie prion protein.
Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
[TBL] [Abstract][Full Text] [Related]
8. Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.
Katorcha E; Makarava N; Savtchenko R; D'Azzo A; Baskakov IV
PLoS Pathog; 2014 Sep; 10(9):e1004366. PubMed ID: 25211026
[TBL] [Abstract][Full Text] [Related]
9. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
[TBL] [Abstract][Full Text] [Related]
10. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
11. Independent amplification of co-infected long incubation period low conversion efficiency prion strains.
Eckland TE; Shikiya RA; Bartz JC
PLoS Pathog; 2018 Oct; 14(10):e1007323. PubMed ID: 30335854
[TBL] [Abstract][Full Text] [Related]
12. Efficient interspecies transmission of synthetic prions.
Block AJ; Shikiya RA; Eckland TE; Kincaid AE; Walters RW; Ma J; Bartz JC
PLoS Pathog; 2021 Jul; 17(7):e1009765. PubMed ID: 34260664
[TBL] [Abstract][Full Text] [Related]
13. Evolving views in prion glycosylation: functional and pathological implications.
Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
[TBL] [Abstract][Full Text] [Related]
14. Prion disease tempo determined by host-dependent substrate reduction.
Mays CE; Kim C; Haldiman T; van der Merwe J; Lau A; Yang J; Grams J; Di Bari MA; Nonno R; Telling GC; Kong Q; Langeveld J; McKenzie D; Westaway D; Safar JG
J Clin Invest; 2014 Feb; 124(2):847-58. PubMed ID: 24430187
[TBL] [Abstract][Full Text] [Related]
15. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
[TBL] [Abstract][Full Text] [Related]
16. Full restoration of specific infectivity and strain properties from pure mammalian prion protein.
Burke CM; Walsh DJ; Steele AD; Agrimi U; Di Bari MA; Watts JC; Supattapone S
PLoS Pathog; 2019 Mar; 15(3):e1007662. PubMed ID: 30908557
[TBL] [Abstract][Full Text] [Related]
17. Expanding spectrum of prion diseases.
Ayers JI; Paras NA; Prusiner SB
Emerg Top Life Sci; 2020 Sep; 4(2):155-167. PubMed ID: 32803268
[TBL] [Abstract][Full Text] [Related]
18. Expression and characterisation of fully posttranslationally modified cellular prion protein in Pichia pastoris.
Marbach J; Zentis P; Ellinger P; Müller H; Birkmann E
Biol Chem; 2013 Nov; 394(11):1475-83. PubMed ID: 23893688
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing.
Stahl N; Baldwin MA; Teplow DB; Hood L; Gibson BW; Burlingame AL; Prusiner SB
Biochemistry; 1993 Mar; 32(8):1991-2002. PubMed ID: 8448158
[TBL] [Abstract][Full Text] [Related]
20. Creutzfeldt-Jakob disease and scrapie prions.
Prusiner SB
Alzheimer Dis Assoc Disord; 1989; 3(1-2):52-78. PubMed ID: 2568118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
